Synergy Pharmaceuticals to Present at Aegis Capital 2013 Healthcare Conference Aegis Capital Healthcare Conference 2013 Business Wire NEW YORK -- September 24, 2013 Synergy Pharmaceuticals, Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal diseases and disorders, today announced that its President and CEO, Gary S. Jacob, Ph.D., will present at the Aegis Capital 2013 Healthcare Conference being held at The Encore at Wynn Las Vegas, September 25-28. The presentation is scheduled for Saturday, September 28^th at 10:30 a.m. (PDT). About Synergy Pharmaceuticals Inc. Synergy Pharmaceuticals is a biopharmaceutical company focused on the development of new drugs to treat patients with gastrointestinal (GI) diseases and disorders. Synergy's lead proprietary drug candidate, plecanatide, is a synthetic analog of the human GI hormone, uroguanylin, and functions by activating the guanylate cyclase-C (GC-C) receptor on epithelial cells of the GI tract. In early 2013, Synergy announced positive results from a large multicenter trial of plecanatide in patients with chronic idiopathic constipation (CIC) and recently completed an end-of-phase 2 meeting with the U.S. Food and Drug Administration (FDA) covering the registration program for plecanatide to treat CIC. Synergy is also developing plecanatide for the treatment of irritable bowel syndrome with constipation (IBS-C), recently announcing that it had reached the halfway mark for total enrollment in a plecanatide phase 2b clinical trial in patients with IBS-C. Synergy’s second GC-C agonist, SP-333, is in clinical development to treat inflammatory bowel disease and other GI conditions and has recently completed its first phase I trial in healthy volunteers. More information is available at www.synergypharma.com . Contact: Synergy Pharmaceuticals Media Contact Gem Gokmen Office: 212-584-7610 Mobile: 646-637-3208 firstname.lastname@example.org or Investor Contact Bernard Denoyer Office: 212-297-0020 Mobile: 203-300-8147 email@example.com
Synergy Pharmaceuticals to Present at Aegis Capital 2013 Healthcare Conference
Press spacebar to pause and continue. Press esc to stop.